<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002181'>Brain edema</z:hpo> is frequently shown after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>It is an expansion of brain volume because of increasing water content in brain </plain></SENT>
<SENT sid="2" pm="."><plain>It causes to increase mortality after <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="17431">Agmatine</z:chebi>, formed by the decarboxylation of <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> by arginine decarboxylase, has been shown to be neuroprotective in trauma and <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> models </plain></SENT>
<SENT sid="4" pm="."><plain>The purpose of this study was to investigate the effect of <z:chebi fb="0" ids="17431">agmatine</z:chebi> for <z:hpo ids='HP_0002181'>brain edema</z:hpo> in ischemic brain damage and to evaluate the expression of aquaporins (AQPs) </plain></SENT>
<SENT sid="5" pm="."><plain>Results showed that <z:chebi fb="0" ids="17431">agmatine</z:chebi> significantly reduced <z:e sem="disease" ids="C1527311" disease_type="Disease or Syndrome" abbrv="">brain swelling</z:e> volume 22 h after 2 h middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in mice </plain></SENT>
<SENT sid="6" pm="."><plain>Water content in brain tissue was clearly decreased 24 h after ischemic injury by <z:chebi fb="0" ids="17431">agmatine</z:chebi> treatment </plain></SENT>
<SENT sid="7" pm="."><plain>Blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) disruption was diminished with <z:chebi fb="0" ids="17431">agmatine</z:chebi> than without </plain></SENT>
<SENT sid="8" pm="."><plain>The expressions of AQPs-1 and -9 were well correlated with <z:hpo ids='HP_0002181'>brain edema</z:hpo> as water channels, were significantly decreased by <z:chebi fb="0" ids="17431">agmatine</z:chebi> treatment </plain></SENT>
<SENT sid="9" pm="."><plain>It can thus be suggested that <z:chebi fb="0" ids="17431">agmatine</z:chebi> could attenuate <z:hpo ids='HP_0002181'>brain edema</z:hpo> by limiting <z:chebi fb="2" ids="33602">BBB</z:chebi> disruption and blocking the accumulation of brain water content through lessening the expression of AQP-1 after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>